Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.620
-0.110 (-6.36%)
At close: Aug 1, 2025, 4:00 PM
1.611
-0.009 (-0.56%)
After-hours: Aug 1, 2025, 7:48 PM EDT

Company Description

Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.

It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.

The company has a strategic alliance with IDT Australia Limited for the development and scale up of its gel-based products across diverse global pharmaceutical, nutraceutical and animal health markets.

Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.

Gelteq Limited
Gelteq logo
CountryAustralia
Founded2018
IPO DateOct 29, 2024
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees8
CEONathan Givoni

Contact Details

Address:
639-641 Glenhuntly Road
Caulfield, VIC 3162
Australia
Phone61 3 9087 3990
Websitegelteq.com

Stock Details

Ticker SymbolGELS
ExchangeNASDAQ
Fiscal YearJuly - June
Reporting CurrencyAUD
IPO Price$4.00
CIK Code0001920092
ISIN NumberAU0000218109
SIC Code2834

Key Executives

NamePosition
Nathan Jacob GivoniCo-Founder, Chief Executive Officer and Executive Director
Simon Hayden SzewachCo-Founder and Non-Executive Chairman
Thuy-Linh GiglerChief Financial Officer
Dr. Paul M. WynneChief Scientific Officer
Adam BendellPresident of U.S. Operations
Matthew JonesHead of Sports Performance

Latest SEC Filings

DateTypeTitle
Jul 25, 2025F-1/A[Amend] Registration statement for certain foreign private issuers
Jul 1, 2025F-1Registration statement for certain foreign private issuers
Jun 30, 20256-KReport of foreign issuer
Mar 14, 20256-KReport of foreign issuer
Nov 15, 202420-FAnnual and transition report of foreign private issuers
Oct 31, 2024NT 20-FNotification of inability to timely file Form 20-F
Oct 30, 20246-KReport of foreign issuer
Oct 28, 2024CERTCertification by an exchange approving securities for listing
Oct 22, 2024424B4Prospectus
Oct 17, 20248-A12BRegistration of securities